Abstract:MicroRNAs can function as key tumor suppressors or oncogenes and act as biomarkers for cancer diagnosis or prognosis. Although high-throughput assays have revealed many miRNA biomarkers for pancreatic ductal adenocarcinoma (PDAC), only a few have been validated in independent populations or investigated for functional significance in PDAC pathogenesis. In this study, we correlated the expression of 36 potentially prognostic miRNAs within PDAC tissue with clinico-pathological features and survival in 151 Chinese patients. We then analyzed the functional roles and target genes of two miRNAs in PDAC development. We found that high expression of miR-186 and miR-326 predict poor and improved survival, respectively. miR-186 was over-expressed in PDAC patients compared with controls, especially in patients with large tumors (> 2 cm), lymph node metastasis, or short-term survival (< 24 months). In contrast, miR-326 was down-regulated in patients compared with controls and displayed relatively increased expression in the patients with long-term survival or without venous invasion. Functional experiments revealed that PDAC cell proliferation and migration was decreased following inhibition and enhanced following over-expression of miR-186. In contrast, it was enhanced following inhibition and decreased after over-expression of miR-326. A luciferase assay indicated that miR-186 can bind directly to the 3'-UTR of NR5A2 to repress gene expression. These findings suggest that miR-186 over-expression contributes to the invasive potential of PDAC, likely via suppression of NR5A2, thereby leading to a poor prognosis; high miR-326 expression prolongs survival likely via the decreasing invasive potential of PDAC cells. These two miRNAs can be used as markers for clinical diagnosis and prognosis, and they represent therapeutic targets for PDAC.

The Role of Mirnas in the Diagnosis, Chemoresistance, and Prognosis of Pancreatic Ductal Adenocarcinoma

Mir-186 And 326 Predict The Prognosis Of Pancreatic Ductal Adenocarcinoma And Affect The Proliferation And Migration Of Cancer Cells

MicroRNAs and pancreatic cancer: Current research and future outlooks

Critical role of miRNAs in pancreatic cancer.

The roles of microRNA in pancreatic cancer progression

Research Progress of Microrna in Diagnosis,treatment and Prognosis Evaluation for Pancreatic Ductal Adenocarcinoma

Overexpressions of Mir-212 Are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma

miRNAs in pancreatic cancer progression and metastasis

The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma

A Novel Defined PANoptosis-Related Mirna Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A Mirna Signature for the Prognosis of Ccrcc

The Multifaceted Role of miR-21 in Pancreatic Cancers

Role of Treg/Th17 Imbalance, Microbiota and Mirnas in Pancreatic Cancer: Therapeutic Options

MicroRNAs in Pancreatic Cancer and Chemoresistance

The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers

Targeting Mirnas for Pancreatic Cancer Therapy.

The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.

Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma

MicroRNAs: emerging biomarkers and therapeutic targets in pancreatic cancer

Identification of biomarkers for the prognosis of pancreatic ductal adenocarcinoma with miRNA microarray data

Prognostic Micrornas and Their Potential Molecular Mechanism in Pancreatic Cancer: A Study Based on the Cancer Genome Atlas and Bioinformatics Investigation

Microrna Signature for Human Pancreatic Cancer Invasion and Metastasis.